Antiretroviral Therapy Perspective

 
 
  • IRIS in HIV: 'Why Is My Patient Getting Worse?' Dr James Brust discusses why some patients experience immune reconstitution inflammatory syndrome, a disease- or pathogen-specific immune response that can mimic an active opportunistic infection.
  • IAS 2021 Read clinically focused news coverage of key developments from IAS 2021
  • A Framework for Comprehensive HIV Primary Care Once viral suppression is achieved, the focus of primary care for people with HIV is in many ways the same as for those without HIV, which increasingly includes the problems associated with aging.
  • CROI 2021 Read clinically focused news coverage of key developments from CROI 2021
  • Contemplating Retirement During COVID-19 Dr Andrew Wilner navigates the tension between his commitment as a physician and the safety of he and his family.
  • HIV and AIDS: Overview Video   Review key aspects of HIV and AIDS —including transmission, disease progression, and prevention and treatment—with this quick overview video.
  • Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
  • ANAC 2020 Read clinically focused news coverage of key developments from ANAC 2020
  • USCHA 2020 Read clinically focused news coverage of key developments from USCA 2020
  • HIV Glasgow 2020 Read clinically focused news coverage of key developments from HIV Glasgow 2020
  • Confronting the HIV Epidemic: Taking Down Silos   Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic.
  • Growing Old With HIV: Beyond Just Surviving The aging of the population with HIV is a medical achievement to celebrate, but with this success comes a new conundrum.
  • Confronting the HIV Epidemic: There's an App for That   UNC physicians and scientists use mobile app technology and gamification strategy to engage at-risk and HIV-positive young men in prevention and management of HIV.
  • Drugs to Avoid in Patients on DOACs DOACs overall have substantially fewer drug-drug interactions than warfarin, but there are still a few to watch out for.
  • AIDS 2020 Read clinically focused news coverage of key developments from IAS 2020
  • Long-acting Injectable Cabotegravir for PrEP Is Promising   Dr Paul Sax discusses the interim results from a study on the use of the long-acting injectable cabotegravir for pre-exposure prophylaxis in cisgender men and transgender women who have sex with men.
  • The Promise of Remdesivir for COVID-19 Treatment   WebMD Chief Medical Officer John Whyte talks with Dr Stuart Cohen about remdesivir for the possible treatment of COVID-19 infection, and when we might expect to see the development of a vaccine.
  • Confronting the HIV Epidemic   Infectious disease experts from UNC Chapel Hill have developed innovative methods to engage young minority men, the fastest-growing HIV-positive population, in the prevention and treatment of HIV.
  • COVID-19 in People With HIV: Commonly Asked Questions   Dr Paul Sax gives answers to some of the most commonly asked questions he has received from patients with HIV.
  • Low-Level Viremia in HIV: When Should We Worry?   Is all low-level viremia in HIV the same, and does it lead to virologic failure? Dr Sax comments on a new study.